'Prope' tolerance in a noncompliant living related small bowel transplant recipient after severe rejection

Transplantation

Volumn 83, Issue 1, 2007, Pages 77-79

  Asolati, Massimo ^a   Testa, Giuliano ^a   Gangemi, Antonio ^a   Sankary, Howard ^a   Oberholzer, José ^a   Benedetti, Enrico ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NONE   (United States)

Author keywords

Living related small bowel transplant; Noncompliant; Prope tolerance

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CASE REPORT; GRAFT RECIPIENT; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REPRODUCIBILITY; SEPSIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; BIOPSY; GRAFT REJECTION; HUMANS; ILEUM; IMMUNOSUPPRESSIVE AGENTS; LIVING DONORS; MALE; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT REFUSAL;

EID: 33846224315     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000239311.87954.fa     Document Type: Article

References (20)

1. Gruessner RW, Sharp HL. Living-related intestinal transplantation: first report of a standardized surgical technique. Transplantation 1997; 64: 1605.
2. Langnas AN. Advances in small-intestine transplantation. Transplantation 2004; 77: S75.
3. The Intestinal Transplantation Registry. Available at: http://www.lhsc.on.ca.itr/.
4. Benedetti E, Testa G, Sankary H, et al. Successful treatment of trauma induced short bowel syndrome with early living related transplantation. J Trauma 2004; 57: 164.
5. Calne RY. Prope tolerance: the future of organ transplantation - from the laboratory to the clinic. Transplantation 2004; 77: 930.
6. Hall BM. Mechanisms of induction of tolerance to organ allografts. Crit Rev Immunol 2000; 20: 267.
7. Strober S, Lowsky RJ, Shizuru JA, Scandling JD, Millan MT. Approaches to transplantation tolerance in humans. Transplantation 2004; 77: 932.
8. Ansari MJ, Sayegh MH. Clinical transplantation tolerance: the promise and challenges. Kidney Int 2004; 65: 1560.
9. Smiley ST, Csizmadia V, Gao W, Turka La, Hancock WW. Differential effects of cyclosporine A, methylprednisolone, mycophenolate and rapamycin on CD154 induction and requirement for NFkappaB: implication for tolerance induction. Transplantation 2000; 70: 415.
10. Billingham RE, Brent L, Medawar PB. Activity acquired tolerance of foreign cells. Nature 1953; 172: 603.
11. Starzl TE. Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A 2004; 101: 14607.
12. Starzl TE, Demetris AJ, Trucco M, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992; 340: 876.
13. Starzl TE, Marchioro TL, Waddell WR. The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surg Gynecol Obstet 1963; 117: 385.
14. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003; 361: 1502.
15. Starzl TE, Murase N, Demetris AJ, et al. Lesson of organ-induced tolerance learned from historical clinical experience. Transplantation 2004; 77: 926.
16. Matzinger P. Tolerance, danger and the extended family. Annu Rev Immunol 1994; 12: 991.
17. Louis S, Giral M, Dupont A, Soulillou JP, Brouard S. Blood cell T populations phenotypes in drug-free 'operationally tolerant' human kidney recipients. Am J Transpl 2004; Suppl 4: 330.
18. Pirenne J, Koshiba T, Geboes K, et al. Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression. Transplantation 2002; 73: 966.
19. Shapiro R, Jordan ML, Basu A, et al. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg 2003; 238: 520.
20. Calne R, Friend P, Moffatt S, et al. Prope tolerance, perioperative Campath 1H and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998; 351: 1701.